Saturday 17 October 2026
Export MKD’s income statement to Excel — free account
MOLECULAR DATA
Follow MKD
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Trend | 2021e | 2022e | 2023e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | — | — |
Analyst estimates 2021–2023 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | — | — | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 505 | 482 | 189 | ||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.00 | 2.71 | 3.94 | 6.16 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 483 | 622 | 1,368 | 1,897 | 1,164 | ||||
| Gross margin, % | — | — | — | — | — | 0.83 | 1.13 | 0.88 | 0.76 | (0.13) | |||||
| EBT | — | — | — | — | — | (17) | (16) | (38) | (28) | (50) | |||||
| EBT margin, % | — | — | — | — | — | (3.52) | (2.57) | (2.78) | (1.46) | (4.29) | |||||
| Net income | — | — | — | — | — | (17) | 0 | 0 | (28) | (50) | |||||
| Depreciation | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 69.00 | 88.86 | 195.43 | 274.69 | 150.40 | ||||
| Earnings | — | — | — | — | — | (0.06) | (0.05) | (0.12) | (4.03) | (6.30) | |||||
| Cash flow | — | — | — | — | — | (3.22) | (3.86) | (2.91) | (1.99) | (4.63) | |||||
| Capex | — | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.04) | 0.33 | |||||
| Free cash flow | — | — | — | — | — | (3.22) | (3.86) | (2.91) | (2.03) | (4.30) | |||||
| Book value | — | — | — | — | — | 0.00 | 0.13 | (1.28) | (4.50) | (0.55) | |||||
| Shares, m | — | — | — | — | — | 7 | 7 | 7 | 7 | 8 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.05 | 0.01 | |||||
| P/B | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.05 | (0.01) | |||||
| EV/FCF | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | (23) | (27) | (20) | (14) | (36) | ||||
| Capex | — | — | — | — | — | 0 | 0 | 0 | 0 | 3 | |||||
| Free cash flow | — | — | — | — | — | (23) | (27) | (20) | (14) | (33) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | 12 | 16 | (27) | (5) | ||||
| Total debt | — | — | — | — | — | — | 33 | 26 | 6 | 11 | |||||
| Net debt | — | — | — | — | — | — | 17 | 25 | (2) | (43) | |||||
| Shareholders’ equity | — | — | — | — | — | — | 1 | (9) | (31) | (4) | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | (28.41) | 0.00 | (78.56) | (57.21) | ||||
| ROIC | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| ROE | — | — | — | — | — | 0.00 | 396.55 | 941.81 | 138.75 | 284.23 | |||||
Negative figures in brackets.
Fiscal years to Dec 2020 · latest quarter Dec 2019
Charts ten years each
MOLECULAR DATA vs peers in Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| WLKP Westlake Chemical Partners LP | $734.5M | 12.8× | 12.3× | −0.01% (below 0%: shrinking) | −2.44% (below 0%: shrinking) | +866.65% (above 0%: growing) | 31.91% | 29.39% | Compare |
| TROX Tronox Holdings PLC | $565.3M | — (loss-making) | — (loss-making) | +18.74% (above 0%: growing) | n/m | +241.51% (above 0%: growing) | 6.34% | (2.42%) | Compare |
| RYAM Rayonier Advanced Materials Inc. | $481.0M | — (loss-making) | — (loss-making) | +10.61% (above 0%: growing) | n/m | +69.92% (above 0%: growing) | 6.10% | (1.69%) | Compare |
| ASIX AdvanSix | $445.5M | — (loss-making) | 24.1× | +2.75% (above 0%: growing) | −89.74% (below 0%: shrinking) | −49.21% (below 0%: shrinking) | 7.38% | 2.15% | Compare |
| VHI Valhi, Inc. | $415.2M | — (loss-making) | 7.0× | +9.82% (above 0%: growing) | +2,500.00% (above 0%: growing) | +435.16% (above 0%: growing) | 22.56% | 9.88% | Compare |
| ASPI ASP Isotopes Inc. | $338.8M | — (loss-making) | — (loss-making) | +327.63% (above 0%: growing) | n/m | −182.92% (below 0%: shrinking) | 28.89% | (667.48%) | Compare |
| BAK Braskem S.A. | $312.3M | — (loss-making) | — | −99.99% (below 0%: shrinking) | n/m | +611.13% (above 0%: growing) | 80.35% | 48.61% | Compare |
| ACNT Ascent Industries Co. | $122.1M | — (loss-making) | — (loss-making) | +37.61% (above 0%: growing) | −89.23% (below 0%: shrinking) | −97.54% (below 0%: shrinking) | 21.62% | (1.02%) | Compare |
| MKD MOLECULAR DATA | $74.9M | — (loss-making) | — (loss-making) | −51.50% (below 0%: shrinking) | n/m | — | 0.83% | 0.00% | |
| Median of peers | $430.4M | — | 12.3× | +10.21% | −45.83% | +155.72% | 22.09% | 0.56% |
MOLECULAR DATA (MKD) Latest News
No news at this impact. Lower the threshold for more.